Motor Activity Clinical Trial
Official title:
Can Cranberry Juice Enhance the Cognition and Motor Accuracy During Multitasking and Alleviate Some Negative Mental and Physiological Consequences of Intense Multitasking in Healthy Adults?
Verified date | February 2024 |
Source | University of Florida |
Contact | Liwei Gu |
Phone | 3522155020 |
lgu[@]ufl.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical trial aims to investigate the effects of a 70-day consumption of cranberry juice on cognitive and motor accuracy, mental and physiological stress, and stress response in healthy men and women between the ages of 30 and 55 who engage in multitasking. The trial will utilize a randomized, double-blinded, placebo-controlled design. It is worth noting that studies have shown that over half of middle-aged Americans experience stress, which can lead to cognitive decline and depression. Previous clinical trials have indicated that consuming polyphenol-rich foods can have positive effects on cognitive function in humans. However, no study to date has examined the long-term effects of cranberry juice consumption on cognitive performance, mental stress, and stress response specifically in individuals engaged in multitasking. Based on this gap in knowledge, the investigators hypothesize the following: (1) chronic consumption of cranberry juice will improve cognitive and motor accuracy, as well as mental and psychological stress responses in young adults subjected to intense multitasking. (2) cranberry juice consumption will alleviate the negative consequences of frequent intense multitasking, such as fatigue, mood fluctuations, cognitive impairment, and memory issues. Additionally, it is expected to have a positive impact on stress biomarkers and neurotransmitter levels. By conducting this clinical trial, the investigators aim to shed light on the potential benefits of cranberry juice consumption in improving cognitive performance, mitigating mental stress, and positively influencing stress responses in individuals who engage in intense multitasking.
Status | Recruiting |
Enrollment | 126 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 55 Years |
Eligibility | Inclusion Criteria: - Weight =110 pounds; - Age 30-55; - BMI 18.9-29.9 kg/m^2; - Education level high school and above Exclusion Criteria: 1. Heavy caffeine user (>300 mg caffeine/day or more than 2 cups of coffee/day); 2. Alcohol consumption (>3 alcohol/week); 3. Smoking (=10 years); 4. Intaking cannabis products; 5. Uncontrolled hypertension; 6. Clinically diagnosed illnesses, such as diabetes, cardiovascular disease, neurological disorders, and mental diseases; 7. Taking medications (antibiotics, etc.) that may influence study outcomes; 8. Taking vitamin/mineral supplements and are not willing to stop for the duration of the study; 9. Have specific dietary restriction (prevent from consuming the standardized breakfast or dinner sandwiches); 10. Inability to perform multitasking; 11. Inability to do blood collection on arm; 12. Inability to being video recorded while performing multitasking; 13. Inability to comply with dietary restrictions for the entire duration of the study; 14. Beck's depression inventory score of =21 during screening; 15. Beck's anxiety inventory score =21 during screening; 16. Severe suicidal tendencies (=2); 17. Having seasonal depression; 18. Pregnancy; 19. Breast-feeding; 20. Female participants will do four pregnancy tests and their menstruation cycle need to be recorded. Female participants who do not wish to do pregnancy tests or record their menstruation cycle will be excluded. |
Country | Name | City | State |
---|---|---|---|
United States | Food/Environment Toxicology Lab | Gainesville | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Florida |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Heart Rate | Heart rate (bpm) will be measured during multitasking. | In baseline visit, for 15 minutes during multitasking; in final visit, for 15 minutes during multitasking. Through study completion, an average of 2 years. | |
Primary | Galvanic Skin Response | Galvanic skin response (micro-Siemens) will be measured during multitasking. | In baseline visit, for 15 minutes during multitasking; in final visit, for 15 minutes during multitasking. Through study completion, an average of 2 years. | |
Primary | Salivary alpha-amylase activity | Salivary alpha-amylase activity will be assessed using ELISA kit. | Through study completion, an average of 2 years. | |
Primary | Salivary cortisol level | Salivary cortisol level will be measured by an enzyme immunoassay with the Cortisol Elisa Assay Kit. | Through study completion, an average of 2 years. | |
Primary | 1. Assessment of Anxiety | Beck's Anxiety Inventory (BAI): presence and intensity of anxiety-related thoughts. During the recruitment process (screening process), potential participants who are having Beck's anxiety inventory score =21 will be excluded from this study.
A higher score means a higher level of anxiety. Minimum Value: 0 Maximum Value: 63 |
During the recruitment process (screening process), potential participants are required to take 3-5 minutes to complete the BAI. Through study completion, an average of 2 years. | |
Primary | 2. Assessment of Anxiety | State-Trait Anxiety Inventory (STAI):
STAI anxiety state (STAI state): the current feeling of anxiety; STAI anxiety trait (STAI trait): the personality trait of anxiety. A higher score means a higher level of anxiety. Minimum Value: 20 Maximum Value: 80 |
During the baseline and final visits, participants are required to take 3-5 minutes to complete the STAI state and STAI trait. Through study completion, an average of 2 years. | |
Primary | 1. Assessment of Mood | Mental fatigue scale (MFS): mental fatigue.
A higher score means a higher level of mental fatigue. Minimum Value: 0 Maximum Value: 42 |
During the baseline and final visits, participants are required to take 3-5 minutes to complete the MFS after NIH toolbox tests. Through study completion, an average of 2 years. | |
Primary | 2. Assessment of Mood | Visual analog mood scales (VAMS): the current mood.
A higher score means a higher level of alert. A higher score means a higher level of inattentive. A higher score means a higher level of strong. A higher score means a higher level of weak. A higher score means a higher level of well-coordinated. A higher score means a higher level of disorganized. A higher score means a higher level of lethargic. A higher score means a higher level of energetic. A higher score means a higher level of incompetent. A higher score means a higher level of competent. A higher score means a higher level of happy. A higher score means a higher level of sad. A higher score means a higher level of interested. A higher score means a higher level of bored. A higher score means a higher level of mentally slow. A higher score means a higher level of quick-witted. Minimum Value: 0 Maximum Value: 100 |
During the baseline and final visits, participants are required to take 3-5 minutes to complete the VAMS after NIH toolbox tests. Through study completion, an average of 2 years. | |
Primary | Assessment of Depression | Beck's depression inventory (BDI): the feeling of depression. During the recruitment process (screening process), potential participants who are having Beck's depression inventory score =21 will be excluded from this study.
A higher score means a higher level of depression. Minimum Value: 0 Maximum Value: 63 |
Participants are required to take 3-5 minutes to complete the BDI during recruitment process, baseline, and final visits. Through study completion, an average of 2 years. | |
Primary | Assessment of Stress | Perceived stress scale (PSS): the feeling of stress.
A higher score means a higher level of stress. Minimum Value: 0 Maximum Value: 40 |
During the baseline and final visits, participants are required to take 3-5 minutes to complete the PSS after NIH toolbox tests. Through study completion, an average of 2 years. | |
Primary | Sleep Assessment | Leeds sleep evaluation (LSE): sleep assessment.
Participants will place marks on a group of 10-cm lines representing they have experienced in variety of symptoms of sleep. Lines extend between extremes like "more difficult than usual" and "easier than usual". Responses are measured using a 100-mm scale and are then averaged to provide a score for each domain. Theses can then be used to evaluate the efficacy and sleep-related side effects of juices. |
During the baseline and final visits, participants are required to take 3-5 minutes to complete the LSE after NIH toolbox tests. Through study completion, an average of 2 years. | |
Primary | Suicide Severity Assessment | Columbia-Suicide Severity Rating Scale (CSSRS): suicide severity rating. During the recruitment process (screening process), potential participants who are having CSSRS (answer YES to actually having thoughts about killing yourself and thinking about you might do this) will be excluded from this study. Also, appropriate actions will be taken to ensure participants safety and well-being. For example, immediately contact a specified consultant and refer the participants who with high level of suicidality to the Crisis Hot Line. Suicidal assessments will also be assessed in V2 and V3 to ensure the participants do not have any suicidal tendencies. In sum, the assessment of suicidal should be completed immediately following the completion of the instruments. | During the recruitment process, baseline, and final visits, participants are required to take 2 minutes to complete the CSSRS. Through study completion, an average of 2 years. | |
Primary | Picture Vocabulary Test | NIH Toolbox Picture Vocabulary Test: to assess participants' ability to understand and identify the meaning of words by matching them to corresponding images. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the Picture Vocabulary Test. Through study completion, an average of 2 years. | |
Primary | Flanker Inhibitory Control and Attention Test | NIH Toolbox Flanker Inhibitory Control and Attention Test: to assess participants' cognitive control and attentional processes, specifically their ability to inhibit irrelevant information and focus on the relevant stimuli. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the Flanker Inhibitory Control and Attention Test. Through study completion, an average of 2 years. | |
Primary | List Sorting Working Memory Test | NIH Toolbox List Sorting Working Memory Test: to assess participants' working memory abilities. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the List Sorting Working Memory Test. Through study completion, an average of 2 years. | |
Primary | Dimensional Changes Card Sort Test | NIH Toolbox Dimensional Changes Card Sort Test: to assess the cognitive flexibility of participants. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the Dimensional Changes Card Sort Test. Through study completion, an average of 2 years. | |
Primary | Pattern Comparison Processing Speed Test | NIH Toolbox Pattern Comparison Processing Speed Test: to assess the cognition processing speed of participants. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the Pattern Comparison Processing Speed Test. Through study completion, an average of 2 years. | |
Primary | Picture Sequence Memory Test | NIH Toolbox Picture Sequence Memory Test: to assess participants' episodic memory. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the Picture Sequence Memory Test. Through study completion, an average of 2 years. | |
Primary | Auditory Verbal Learning Test | Auditory Verbal Learning Test: to assess participants' attention, memory, and learning ability in the auditory-verbal domain. | During the baseline and final visits, participants are required to take about 40-50 minutes to complete the Auditory Verbal Learning Test. Through study completion, an average of 2 years. | |
Primary | Fecal Content of Acetic acid, Propionic acid, and Butyric acid | Fecal content of acetic acid, propionic acid, and butyric acid will be determined using gas chromatography with a flame ionization detector. | Participants are required to provide their fecal samples on the baseline and final visit. Through study completion, an average of 2 years. Through study completion, an average of 2 years. | |
Primary | Brain-derived neurotrophic factor (BDNF) Levels in Plasma | BDNF levels in plasma will be measured using ELISA kit. | A certified nurse will perform a blood draw for participants during both the baseline and final visits, using two tubes, resulting in a total of 20 mL. Through study completion, an average of 2 years. | |
Primary | Neurotransmitters Analysis | Monoamine oxidase (MAO) activity in plasma will be determined using the Amplex Red MAO Assay Kit. | A certified nurse will perform a blood draw for participants during both the baseline and final visits, using two tubes, resulting in a total of 20 mL. Through study completion, an average of 2 years. | |
Primary | 1. Neurotransmitters Analysis | Plasma levels of tryptophan metabolites (3-indole propionic acid, Indole-3-aldehyde , Serotonin, and Melatonin) will be quantified using the targeted metabolomic method on UHPLC-MS/MS. | A certified nurse will perform a blood draw for participants during both the baseline and final visits, using two tubes, resulting in a total of 20 mL. Through study completion, an average of 2 years. | |
Primary | 2. Neurotransmitters Analysis | Plasma levels of catecholamines (Dopamine, Epinephrine, and Norepinephrine) will be quantified using the targeted metabolomic method on UHPLC-MS/MS. | A certified nurse will perform a blood draw for participants during both the baseline and final visits, using two tubes, resulting in a total of 20 mL. Through study completion, an average of 2 years. | |
Primary | 3. Neurotransmitters Analysis | Plasma levels of histamine will be quantified using the targeted metabolomic method on UHPLC-MS/MS. | A certified nurse will perform a blood draw for participants during both the baseline and final visits, using two tubes, resulting in a total of 20 mL. Through study completion, an average of 2 years. | |
Primary | 4. Neurotransmitters Analysis | Plasma levels of Gamma-Aminobutyric acid (GABA) will be quantified using the targeted metabolomic method on UHPLC-MS/MS. | A certified nurse will perform a blood draw for participants during both the baseline and final visits, using two tubes, resulting in a total of 20 mL. Through study completion, an average of 2 years. | |
Primary | 24-Hour Food Record | 24-hour dietary record will be completed by participants using an Automated Self-Administered Dietary Assessment Tool. | During the baseline and final visits, participants are required to take about 10-15 minutes to complete the 24-Hour Food Record. Through study completion, an average of 2 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06315036 -
Effects of Developmental Gymnastics on Preschoolers' Motor Skills
|
N/A | |
Terminated |
NCT02936726 -
Examining Exercise, Health Coaching and Meditation for University Employees
|
N/A | |
Completed |
NCT02915913 -
Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults
|
N/A | |
Completed |
NCT03162484 -
Physical Activity and Chronic Acquired Brain Injury
|
N/A | |
Completed |
NCT02329262 -
A Skills-based RCT for Physical Activity Using Peer Mentors
|
N/A | |
Completed |
NCT02158130 -
Effects of Aerobic Exercise Detraining
|
N/A | |
Terminated |
NCT01404039 -
Investigating Motor Cortex Processing for Pain Modulation
|
Phase 1 | |
Completed |
NCT01188044 -
Validating Accelerometers to Study Physical Activity of Toddlers
|
N/A | |
Completed |
NCT01697124 -
The Children in Action Feasibility Study
|
N/A | |
Not yet recruiting |
NCT04035863 -
Effects of Photobiomodulation on Superficial Sensitivity and Muscle Activity of Individuals With Myelomeningocele
|
N/A | |
Completed |
NCT03695523 -
PLAY (PhysicaL ActivitY) Policy Study
|
N/A | |
Active, not recruiting |
NCT05012241 -
The Reliability of the Nine Hole Peg Test in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT03826030 -
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
|
Phase 2 | |
Completed |
NCT05033197 -
Physical Activity, Cognition, Motor Skills, and Well-beings
|
N/A | |
Completed |
NCT03146169 -
Training Program for Community Health Campaign: Fitter Families Project
|
N/A | |
Completed |
NCT03166020 -
Evaluation of a Video-ludic Re-education of the Paretic Upper Limb in Chronic Hemipartic Patients Post Cerebral Vascular Accident
|
N/A | |
Recruiting |
NCT02264275 -
Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents
|
N/A | |
Completed |
NCT02432924 -
Using Combined Instantaneous and Multidimensional Feedback to Support a Change in Physical Activity Behaviour
|
N/A | |
Completed |
NCT01697475 -
Text-Messaging to Motivate Walking in Older African Americans
|
N/A | |
Completed |
NCT04547569 -
Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning
|
N/A |